These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 26637979)

  • 1. SLC39A8 Deficiency: A Disorder of Manganese Transport and Glycosylation.
    Park JH; Hogrebe M; Grüneberg M; DuChesne I; von der Heiden AL; Reunert J; Schlingmann KP; Boycott KM; Beaulieu CL; Mhanni AA; Innes AM; Hörtnagel K; Biskup S; Gleixner EM; Kurlemann G; Fiedler B; Omran H; Rutsch F; Wada Y; Tsiakas K; Santer R; Nebert DW; Rust S; Marquardt T
    Am J Hum Genet; 2015 Dec; 97(6):894-903. PubMed ID: 26637979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-glycome analysis detects dysglycosylation missed by conventional methods in SLC39A8 deficiency.
    Park JH; Mealer RG; Elias AF; Hoffmann S; Grüneberg M; Biskup S; Fobker M; Haven J; Mangels U; Reunert J; Rust S; Schoof J; Schwanke C; Smoller JW; Cummings RD; Marquardt T
    J Inherit Metab Dis; 2020 Nov; 43(6):1370-1381. PubMed ID: 32852845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A SLC39A8 variant causes manganese deficiency, and glycosylation and mitochondrial disorders.
    Riley LG; Cowley MJ; Gayevskiy V; Roscioli T; Thorburn DR; Prelog K; Bahlo M; Sue CM; Balasubramaniam S; Christodoulou J
    J Inherit Metab Dis; 2017 Mar; 40(2):261-269. PubMed ID: 27995398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autosomal-Recessive Intellectual Disability with Cerebellar Atrophy Syndrome Caused by Mutation of the Manganese and Zinc Transporter Gene SLC39A8.
    Boycott KM; Beaulieu CL; Kernohan KD; Gebril OH; Mhanni A; Chudley AE; Redl D; Qin W; Hampson S; Küry S; Tetreault M; Puffenberger EG; Scott JN; Bezieau S; Reis A; Uebe S; Schumacher J; Hegele RA; McLeod DR; Gálvez-Peralta M; Majewski J; Ramaekers VT; ; Nebert DW; Innes AM; Parboosingh JS; Abou Jamra R
    Am J Hum Genet; 2015 Dec; 97(6):886-93. PubMed ID: 26637978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical, molecular and glycophenotype insights in SLC39A8-CDG.
    Bonaventura E; Barone R; Sturiale L; Pasquariello R; Alessandrì MG; Pinto AM; Renieri A; Panteghini C; Garavaglia B; Cioni G; Battini R
    Orphanet J Rare Dis; 2021 Jul; 16(1):307. PubMed ID: 34246313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galactose Supplementation in Patients With TMEM165-CDG Rescues the Glycosylation Defects.
    Morelle W; Potelle S; Witters P; Wong S; Climer L; Lupashin V; Matthijs G; Gadomski T; Jaeken J; Cassiman D; Morava E; Foulquier F
    J Clin Endocrinol Metab; 2017 Apr; 102(4):1375-1386. PubMed ID: 28323990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional analysis of SLC39A8 mutations and their implications for manganese deficiency and mitochondrial disorders.
    Choi EK; Nguyen TT; Gupta N; Iwase S; Seo YA
    Sci Rep; 2018 Feb; 8(1):3163. PubMed ID: 29453449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in COG2 encoding a subunit of the conserved oligomeric golgi complex cause a congenital disorder of glycosylation.
    Kodera H; Ando N; Yuasa I; Wada Y; Tsurusaki Y; Nakashima M; Miyake N; Saitoh S; Matsumoto N; Saitsu H
    Clin Genet; 2015 May; 87(5):455-60. PubMed ID: 24784932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SLC39A8 deficiency: biochemical correction and major clinical improvement by manganese therapy.
    Park JH; Hogrebe M; Fobker M; Brackmann R; Fiedler B; Reunert J; Rust S; Tsiakas K; Santer R; Grüneberg M; Marquardt T
    Genet Med; 2018 Feb; 20(2):259-268. PubMed ID: 28749473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biallelic variants in SLC35C1 as a cause of isolated short stature with intellectual disability.
    Knapp KM; Luu R; Baerenfaenger M; Zijlstra F; Wessels HJCT; Jenkins D; Lefeber DJ; Neas K; Bicknell LS
    J Hum Genet; 2020 Sep; 65(9):743-750. PubMed ID: 32313197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exome sequence identified a c.320A > G ALG13 variant in a female with infantile epileptic encephalopathy with normal glycosylation and random X inactivation: Review of the literature.
    Hamici S; Bastaki F; Khalifa M
    Eur J Med Genet; 2017 Oct; 60(10):541-547. PubMed ID: 28778787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The schizophrenia risk locus in SLC39A8 alters brain metal transport and plasma glycosylation.
    Mealer RG; Jenkins BG; Chen CY; Daly MJ; Ge T; Lehoux S; Marquardt T; Palmer CD; Park JH; Parsons PJ; Sackstein R; Williams SE; Cummings RD; Scolnick EM; Smoller JW
    Sci Rep; 2020 Aug; 10(1):13162. PubMed ID: 32753748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital disorders of glycosylation type IIb with MOGS mutations cause early infantile epileptic encephalopathy, dysmorphic features, and hepatic dysfunction.
    Anzai R; Tsuji M; Yamashita S; Wada Y; Okamoto N; Saitsu H; Matsumoto N; Goto T
    Brain Dev; 2021 Mar; 43(3):402-410. PubMed ID: 33261925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TMEM165 deficiency causes a congenital disorder of glycosylation.
    Foulquier F; Amyere M; Jaeken J; Zeevaert R; Schollen E; Race V; Bammens R; Morelle W; Rosnoblet C; Legrand D; Demaegd D; Buist N; Cheillan D; Guffon N; Morsomme P; Annaert W; Freeze HH; Van Schaftingen E; Vikkula M; Matthijs G
    Am J Hum Genet; 2012 Jul; 91(1):15-26. PubMed ID: 22683087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predominant and novel de novo variants in 29 individuals with ALG13 deficiency: Clinical description, biomarker status, biochemical analysis, and treatment suggestions.
    Ng BG; Eklund EA; Shiryaev SA; Dong YY; Abbott MA; Asteggiano C; Bamshad MJ; Barr E; Bernstein JA; Chelakkadan S; Christodoulou J; Chung WK; Ciliberto MA; Cousin J; Gardiner F; Ghosh S; Graf WD; Grunewald S; Hammond K; Hauser NS; Hoganson GE; Houck KM; Kohler JN; Morava E; Larson AA; Liu P; Madathil S; McCormack C; Meeks NJL; Miller R; Monaghan KG; Nickerson DA; Palculict TB; Papazoglu GM; Pletcher BA; Scheffer IE; Schenone AB; Schnur RE; Si Y; Rowe LJ; Serrano Russi AH; Russo RS; Thabet F; Tuite A; Villanueva MM; Wang RY; Webster RI; Wilson D; Zalan A; ; Wolfe LA; Rosenfeld JA; Rhodes L; Freeze HH
    J Inherit Metab Dis; 2020 Nov; 43(6):1333-1348. PubMed ID: 32681751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SLC39A8 gene encoding a metal ion transporter: discovery and bench to bedside.
    Nebert DW; Liu Z
    Hum Genomics; 2019 Sep; 13(Suppl 1):51. PubMed ID: 31521203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic metal ion transporter ZIP8 regulates manganese homeostasis and manganese-dependent enzyme activity.
    Lin W; Vann DR; Doulias PT; Wang T; Landesberg G; Li X; Ricciotti E; Scalia R; He M; Hand NJ; Rader DJ
    J Clin Invest; 2017 Jun; 127(6):2407-2417. PubMed ID: 28481222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of novel mutations in MOGS in a Chinese patient with infantile spams.
    Peiwei Zhao ; Peng X; Luo S; Huang Y; Tan L; Shao J; He X
    Neurogenetics; 2020 Apr; 21(2):97-104. PubMed ID: 31925597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De novo mutations in SLC35A2 encoding a UDP-galactose transporter cause early-onset epileptic encephalopathy.
    Kodera H; Nakamura K; Osaka H; Maegaki Y; Haginoya K; Mizumoto S; Kato M; Okamoto N; Iai M; Kondo Y; Nishiyama K; Tsurusaki Y; Nakashima M; Miyake N; Hayasaka K; Sugahara K; Yuasa I; Wada Y; Matsumoto N; Saitsu H
    Hum Mutat; 2013 Dec; 34(12):1708-14. PubMed ID: 24115232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficiency of dolichol-phosphate-mannose synthase-1 causes congenital disorder of glycosylation type Ie.
    Imbach T; Schenk B; Schollen E; Burda P; Stutz A; Grunewald S; Bailie NM; King MD; Jaeken J; Matthijs G; Berger EG; Aebi M; Hennet T
    J Clin Invest; 2000 Jan; 105(2):233-9. PubMed ID: 10642602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.